Several tech startups — Autoscience, RAAPID, Mave Health, among others, have announced their venture capital funding to bolster innovation and business growth.
Autoscience Raises $14 mn
Autoscience raised $14 million in seed funding led by General Catalyst, with participation from Toyota Ventures, Perplexity Fund, MaC Ventures, and S32. Founded by CEO Eliot Cowan and a team from Google X, MIT, and Harvard, the company is building an autonomous AI research lab powered by “AI scientists” and “AI engineers.” Its platform automates the invention, validation, and deployment of machine learning models, accelerating R&D cycles. The funding will support enterprise deployment across industries like finance and manufacturing. Strategically, investors are backing scalable AI-driven innovation to overcome human bottlenecks in research and enable continuous model development.
RAAPID Secures Series A Extension
RAAPID, founded by CEO Chetan Parikh, secured a Series A extension backed by UPMC Enterprises, joining existing investor M12 (Microsoft’s venture fund). The company develops a neuro-symbolic AI platform for medical coding and risk adjustment, combining machine learning with clinical reasoning for audit-ready accuracy. The funding partnership supports co-development with healthcare systems and accelerates deployment across Medicare Advantage and health networks. Strategically, the investment reflects demand for explainable, compliance-first AI in healthcare. The capital will expand platform capabilities, enhance regulatory alignment, and scale adoption of AI-driven clinical intelligence solutions in highly regulated environments.
Mave Health Raises $2.1 mn
Mave Health raised $2.1 million in seed funding led by Blume Ventures to advance its neurotechnology platform focused on stress and cognitive performance. Founded by a multidisciplinary team in neuroscience and engineering, the company develops non-invasive brain stimulation and AI-driven mental wellness solutions. The funding will support product development, clinical validation, and commercialization of its wearable technology. Strategically, the partnership reflects increasing investor interest in digital health and neurotech innovation. The platform leverages real-time neural data and AI algorithms to deliver personalized interventions, positioning Mave Health within the growing market for preventive mental healthcare technologies.
Sands Capital Raises $1.1 bn
Sands Capital announced the successful close of Global Innovation Fund III with $1.1 billion, backed by key investors including Canada Pension Plan Investment Board (CPP Investments) and Hamilton Lane. The fund is designed to partner with leading high-growth technology companies in sectors such as AI, industrial technology, and intelligent infrastructure. Led by executives including Barron Martin (Managing Partner) and Frank Sands (CEO & CIO), the fund targets a concentrated portfolio of category-defining companies. This venture capital initiative enables long-term partnerships with founders, providing growth capital to scale operations and transition into global public technology leaders.
THASNIYA VP
